A detailed history of Royce & Associates LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 315,198 shares of TMDX stock, worth $47 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
315,198
Previous 351,698 10.38%
Holding current value
$47 Million
Previous $27.8 Million 16.05%
% of portfolio
0.22%
Previous 0.26%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$70.86 - $89.93 $2.59 Million - $3.28 Million
-36,500 Reduced 10.38%
315,198 $23.3 Million
Q4 2023

Feb 12, 2024

BUY
$36.74 - $81.08 $7.72 Million - $17 Million
210,000 Added 148.2%
351,698 $27.8 Million
Q3 2023

Nov 09, 2023

BUY
$53.47 - $96.07 $224,467 - $403,301
4,198 Added 3.05%
141,698 $7.76 Million
Q2 2023

Aug 07, 2023

SELL
$66.23 - $88.73 $1.46 Million - $1.95 Million
-22,000 Reduced 13.79%
137,500 $11.5 Million
Q1 2023

May 04, 2023

SELL
$53.63 - $82.33 $1.74 Million - $2.68 Million
-32,500 Reduced 16.93%
159,500 $12.1 Million
Q4 2022

May 23, 2023

BUY
$39.08 - $64.29 $1.27 Million - $2.09 Million
32,500 Added 20.38%
192,000 $11.9 Million
Q4 2022

Feb 13, 2023

BUY
$39.08 - $64.29 $1.56 Million - $2.57 Million
40,000 Added 26.32%
192,000 $11.9 Million
Q3 2022

Nov 03, 2022

BUY
$31.56 - $55.75 $315,600 - $557,500
10,000 Added 7.04%
152,000 $6.34 Million
Q2 2022

Aug 04, 2022

BUY
$20.56 - $32.15 $1.13 Million - $1.77 Million
55,000 Added 63.22%
142,000 $4.47 Million
Q1 2022

May 05, 2022

BUY
$12.58 - $26.94 $327,080 - $700,440
26,000 Added 42.62%
87,000 $2.34 Million
Q4 2021

Feb 07, 2022

BUY
$19.16 - $32.68 $1.17 Million - $1.99 Million
61,000 New
61,000 $1.17 Million
Q4 2020

Feb 08, 2021

SELL
$11.91 - $19.9 $488,310 - $815,899
-41,000 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$13.78 - $18.84 $564,980 - $772,440
41,000 New
41,000 $565,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $4.74B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.